Information:
Fel:
ID
39203
Beskrivning
Intensive Vasodilator Therapy in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT01180413
Länk
https://clinicaltrials.gov/show/NCT01180413
Nyckelord
Versioner (1)
- 2019-12-10 2019-12-10 -
Rättsinnehavare
See clinicaltrials.gov
Uppladdad den
10 december 2019
DOI
För en begäran logga in.
Licens
Creative Commons BY 4.0
Modellkommentarer :
Här kan du kommentera modellen. Med hjälp av pratbubblor i Item-grupperna och Item kan du lägga in specifika kommentarer.
Itemgroup-kommentar för :
Item-kommentar för :
Du måste vara inloggad för att kunna ladda ner formulär. Var vänlig logga in eller registrera dig utan kostnad.
Eligibility Essential Hypertension NCT01180413
Eligibility Essential Hypertension NCT01180413
- StudyEvent: Eligibility
Similar models
Eligibility Essential Hypertension NCT01180413
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datatyp
Alias
Antihypertensive therapy
Item
ongoing antihypertensive treatment for >3 months
boolean
C0585941 (UMLS CUI [1])
Blood pressure determination During Antihypertensive therapy
Item
blood pressure >120/75 during antihypertensive treatment
boolean
C0005824 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0585941 (UMLS CUI [1,3])
C0347984 (UMLS CUI [1,2])
C0585941 (UMLS CUI [1,3])
Cardiac ejection fraction
Item
ejection fraction > 45%
boolean
C0232174 (UMLS CUI [1])
Blood pressure determination
Item
blood pressure >160/100
boolean
C0005824 (UMLS CUI [1])
Pregnancy
Item
pregnancy
boolean
C0032961 (UMLS CUI [1])
Childbearing Potential Contraceptive methods Absent
Item
fertile women not using safe contraceptives
boolean
C3831118 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
C0700589 (UMLS CUI [1,2])
C0332197 (UMLS CUI [1,3])
Secondary hypertension
Item
known secondary hypertension
boolean
C0155616 (UMLS CUI [1])
Valvular disease Hemodynamic Significant
Item
valvular disease of haemodynamic significance
boolean
C3258293 (UMLS CUI [1,1])
C0019010 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
C0019010 (UMLS CUI [1,2])
C0750502 (UMLS CUI [1,3])
Endocrine System Disease | Kidney Disease | Liver disease
Item
known endocrine disease, nephropathy or hepatic disease
boolean
C0014130 (UMLS CUI [1])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
C0022658 (UMLS CUI [2])
C0023895 (UMLS CUI [3])
Malignant disease
Item
present malignant disease
boolean
C0442867 (UMLS CUI [1])
Mental disorder
Item
known psychiatric disease
boolean
C0004936 (UMLS CUI [1])
Laboratory test result abnormal
Item
abnormal lab tests of clinical significance
boolean
C0438215 (UMLS CUI [1])
Hypersensitivity Investigational New Drugs
Item
known allergy to any study medication
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0013230 (UMLS CUI [1,2])
Body mass index
Item
body mass index > 35
boolean
C1305855 (UMLS CUI [1])
Antihypertensive therapy | Combined Modality Therapy | Angiotensin-Converting Enzyme Inhibitors | Calcium Channel Blockers
Item
ongoing antihypertensive treatment with a combination of ace-inhibitor and calcium antagonist.
boolean
C0585941 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C0006684 (UMLS CUI [4])
C0009429 (UMLS CUI [2])
C0003015 (UMLS CUI [3])
C0006684 (UMLS CUI [4])